Jasper Therapeutics Inc. (NASDAQ: JSPR) Stock Information | RedChip

Jasper Therapeutics Inc. (NASDAQ: JSPR)


$21.9350
+0.0950 ( -0.07% ) 44.0K

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Market Data


Open


$21.9350

Previous close


$21.8400

Volume


44.0K

Market cap


$328.61M

Day range


$21.1660 - $23.0000

52 week range


$4.0000 - $31.0100

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 73 Nov 07, 2024
8-k 8K-related 16 Nov 07, 2024
8-k 8K-related 16 Oct 15, 2024
4 Insider transactions 1 Sep 12, 2024
10-q Quarterly Reports 75 Aug 13, 2024
3 Insider transactions 2 Jun 20, 2024
4 Insider transactions 1 Jun 20, 2024
8-k 8K-related 16 Jun 20, 2024
4 Insider transactions 2 Jun 12, 2024
8-k 8K-related 18 Jun 12, 2024

Latest News